Day: November 28, 2022

Sanders’ 25-year career focus on services spans global-scale IT, security and networking businesses with deep experience in service delivery transformation BURLINGTON, Mass., Nov. 28, 2022 (GLOBE NEWSWIRE) — Avid® (Nasdaq: AVID) today announced the promotion of technology services executive Deb Sanders to the role of Chief Customer Officer & Senior Vice President to lead worldwide operations for customer success, customer care, advocacy, learning and overall CX, as well as oversee collaboration with the customer-led Avid Community Association. Deb Sanders joined Avid as Vice President of Global Customer Care in 2019 with responsibility for the vision, strategy and tactical plans for the global customer care organization supporting thousands of large media enterprises and hundreds of thousands of creative individuals who rely...

Woburn, Nov. 28, 2022 (GLOBE NEWSWIRE) — Biofrontera Inc. (“Biofrontera” or the “Company”) (NASDAQ: BFRI), announced today that they will be participating in Renmark Financial Communications Inc.’s live Virtual Non-Deal Roadshow Series to discuss its latest investor presentation on Wednesday, November 30, 2022, at 12:00 PM EST, Monday, December 5, 2022, at 1:00 PM CST, Friday, December 9, 2022 at 12:00 PM EST and Monday, December 19, 2022 at 1:00 PM PST. Biofrontera Inc. welcomes stakeholders, investors, and other individual followers to register and attend these live events. The presentation will feature Prof. Hermann Luebbert, Executive Chairman, Erica Monaco, CEO, and Fred Leffler, CFO. Topics to be covered will include the investor presentation including the latest company news, followed by a live Q&A....

Successful completion of TSX listing review Expansion of adult-use portfolio into key fifth province 5 provinces now selling Aleafia’s adult-use productsTORONTO, Nov. 28, 2022 (GLOBE NEWSWIRE) — Further to its previous announcements, Aleafia Health Inc. (TSX: AH, OTCQB: ALEAF) (“Aleafia Health” or the “Company”) is pleased to announce that it has completed the TSX delisting review and confirms that the Company satisfies the Toronto Stock Exchange’s requirements for continued listing. Aleafia Health will continue to trade on the TSX without further review at this time. “We are very pleased that the TSX has completed its five-month long review process and the Company is no longer being assessed for potential delisting. Over that time period, Aleafia has demonstrated performance in its key financial metrics,” said Tricia Symmes,...

Presentation to Focus on Progress of Pan-Coronavirus (Universal) Vaccines to Protect Against Evolving Variants ATLANTA, GA, Nov. 28, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing vaccines and immunotherapies against infectious diseases and cancers, today announced that Mark J. Newman, Ph.D., Chief Scientific Officer of GeoVax, will present at the World Vaccine & Immunotherapy Congress (WVIC) West Coast 2022, taking place November 28-December 1, 2022, in San Diego, California. Dr. Newman will discuss the design and evaluation of MVA-vectored vaccines against betacoronaviruses and GeoVax’s progress toward producing vaccines that are more potent, induce broader immune responses, function in immunocompromised patients and individuals underserved by existing...

EDMONTON, Alberta, Nov. 28, 2022 (GLOBE NEWSWIRE) — Regenx Tech Corp., (the “Company” or “Regenx“) (TSXV: RGX) (OTCQB: RGXTF) (FSE: YRS WKN: A2DSW3) announces the Company has granted an aggregate of 3,900,000 stock options to directors, officers, employees, and various consultants of the Company. The options are at an exercise price of $0.05 per share and valid for a period of five years from the date of the grant, subject to vesting provisions. The options are granted in accordance with the Company’s Stock Option Plan approved by the shareholders on July 27, 2022. The grant of the options has been approved by the Board of Directors and is subject to the final approval of the TSX Venture Exchange. About Regenx Regenx is positioned for growth in the CleanTech sector through the development and commercialization...

Stock Exchange Release 28th of November 2022 at 5 pm (CET +1) Sp Mortgage Bank Plc and Oma Savings Bank Plc have 28.11.2022 signed an agreement on selling the mortgages originated by Lieto Savings Bank and currently held by Sp Mortgage Bank Plc to Oma savings Bank Plc. The signed agreement is part of a wider set of transactions whereby Lieto Savings Bank will sell its entire banking business to Oma Savings Bank plc.  The mortgages to be sold by Sp Mortgage Bank Plc to Oma Savings Bank Plc amount to roughly EUR 250 mio as per November 22nd 2022. After the sale Oma Savings Bank Plc carries all rights and responsibilities relating to the mortgages. The final volume of the mortgages subject to the transaction will be determined by the time the mortgages will be transferred to Oma Savings Bank. Further information: Karri Alameri, Managing Director,...

Aktia Bank PlcStock Exchange Release28 November 2022 at 05.00 p.m. Aktia Bank Plc – Managers’ transactions – Anssi Huhta____________________________________________ Person subject to the notification requirementName: Huhta, AnssiPosition: Other senior managerIssuer: Aktia Bank plcLEI: 743700GC62JLHFBUND16 Notification type: INITIAL NOTIFICATIONReference number: 743700GC62JLHFBUND16_20221125103902_116____________________________________________ Transaction date: 2022-11-24Venue not applicableInstrument type: SHAREISIN: FI4000058870Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE Transaction details(1): Volume: 822 Unit price: 0.00 EUR Aggregated transactions(1): Volume: 822 Volume weighted average price: 0.00 EUR AKTIA BANK PLC For more information:Ari Syrjäläinen, General Counsel, tel. +358 50 362 9587 Distribution:Nasdaq...

Aktia Bank PlcStock Exchange Release28 November 2022 at 05.00 p.m. Aktia Bank Plc – Managers’ transactions – Outi Henriksson____________________________________________ Person subject to the notification requirementName: Henriksson, OutiPosition: Chief Financial OfficerIssuer: Aktia Bank plcLEI: 743700GC62JLHFBUND16 Notification type: INITIAL NOTIFICATIONReference number: 743700GC62JLHFBUND16_20221125103902_115____________________________________________ Transaction date: 2022-11-24Venue not applicableInstrument type: SHAREISIN: FI4000058870Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE Transaction details(1): Volume: 551 Unit price: 0.00 EUR Aggregated transactions(1): Volume: 551 Volume weighted average price: 0.00 EUR AKTIA BANK PLC For more information:Ari Syrjäläinen, General Counsel, tel. +358 50 362 9587 Distribution:Nasdaq...